Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 22;32(2):298-305.
doi: 10.1093/icvts/ivaa259.

A detailed explantation assessment protocol for patients with left ventricular assist devices with myocardial recovery

Affiliations

A detailed explantation assessment protocol for patients with left ventricular assist devices with myocardial recovery

María Monteagudo Vela et al. Interact Cardiovasc Thorac Surg. .

Abstract

Objectives: Left ventricular assist device (LVAD) implantation for end-stage heart failure patients has been on the rise, providing a reliable long-term option. For some LVAD patients, longer term LV unloading leads to recovery; hence, the need for evaluating potential myocardial recovery and weaning eligibility has emerged.

Methods: All patients who underwent contemporary LVAD explantation at our institution between 2009 and 2020 were included in the study. Patients in New York Heart Association I, left ventricular ejection fraction >40%, a cardiac index >2.4 l/min and a peak oxygen intake >50% predicted underwent a 4-phase weaning assessment. A minimally invasive approach using a titanium plug was the surgery of choice in the most recent explants. Kaplan-Meier curves were used to estimate the survival at 1 and 5 years.

Results: Twenty-six patients (17 HeartMate II, 9 HeartWare) underwent LVAD explantation after a median 317 days of support [IQ (212-518)], range 131-1437. Mean age at explant was 35.8 ± 12.7 years and 85% were males. Idiopathic dilated cardiomyopathy was the underlying diagnosis in 70% of cases. Thirteen (48%) patients were on short-term mechanical circulatory support and 60% required intensive care unit admission prior to the LVAD implantation. At 1 year, Kaplan-Meier estimated survival was 88%, whereas at 6 years, it was 77%. The average left ventricular ejection fraction at 1 year post-explant was 44.25% ± 8.44.

Conclusions: The use of a standardized weaning protocol (echocardiographic and invasive) and a minimally invasive LVAD explant technique minimizes periprocedural complications and leads to good long-term device-free survival rates.

Keywords: Left ventricular assist device; Left ventricular assist device explantation; Minimal invasive approach; Myocardial recovery; Occlusion test.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Inclusion criteria. LVAD: left ventricular assist device.
Figure 2:
Figure 2:
Scheme of medical and interventional protocol. CI: cardiac index; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVEF: left ventricular ejection fraction; PCWP: pulmonary capillary wedge pressure; VE/VCO2: minute ventilation relative to carbon dioxide production.
Figure 3:
Figure 3:
Plug placed in the left ventricle.
Figure 4:
Figure 4:
Comparison between mean pulmonary artery pressures and wedge with full flow LVAD, minimum speed and LVAD off and occluded. LVAD: left ventricular assist device.
Figure 5:
Figure 5:
Survival from explant shown in days.
None

Similar articles

Cited by

  • Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure.
    Jedrzejewska A, Braczko A, Kawecka A, Hellmann M, Siondalski P, Slominska E, Kutryb-Zajac B, Yacoub MH, Smolenski RT. Jedrzejewska A, et al. Int J Mol Sci. 2022 Aug 31;23(17):9886. doi: 10.3390/ijms23179886. Int J Mol Sci. 2022. PMID: 36077285 Free PMC article. Review.
  • A Peek at LVADs Pumping to Recovery.
    Arshad S, Cutting RD, Stephens DJ, Goldberg YH, Mahr C, Vyasabattu M, Abdelfattah AH, Vaidya GN. Arshad S, et al. Clin Med Insights Cardiol. 2022 Dec 26;16:11795468221144352. doi: 10.1177/11795468221144352. eCollection 2022. Clin Med Insights Cardiol. 2022. PMID: 36601071 Free PMC article.
  • Myocardial Recovery.
    Chrysakis N, Xanthopoulos A, Magouliotis D, Starling RC, Drakos SG, Triposkiadis F, Skoularigis J. Chrysakis N, et al. Diagnostics (Basel). 2023 Apr 21;13(8):1504. doi: 10.3390/diagnostics13081504. Diagnostics (Basel). 2023. PMID: 37189604 Free PMC article. Review.
  • HeartMate 3 Explantation Using Felt Plug for Ventriculotomy Occlusion.
    Medina M, Alam A, Bindra A, Patel N, Guerrero-Miranda C, Fetten K, Meyer DM, Rafael-Yarihuaman AE. Medina M, et al. Methodist Debakey Cardiovasc J. 2023 May 8;19(1):43-48. doi: 10.14797/mdcvj.1208. eCollection 2023. Methodist Debakey Cardiovasc J. 2023. PMID: 37188100 Free PMC article.
  • A Holistic View of Advanced Heart Failure.
    Triposkiadis F, Giamouzis G, Kitai T, Skoularigis J, Starling RC, Xanthopoulos A. Triposkiadis F, et al. Life (Basel). 2022 Aug 24;12(9):1298. doi: 10.3390/life12091298. Life (Basel). 2022. PMID: 36143336 Free PMC article. Review.

References

    1. Roger VL. Epidemiology of heart failure. Circ Res 2013;113:646–59. - PMC - PubMed
    1. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation 2020;141:e139–596. - PubMed
    1. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241–51. - PubMed
    1. Jakovljevic DG, Yacoub MH, Schueler S, MacGowan GA, Velicki L, Seferovic PM et al. Left ventricular assist device as a bridge to recovery for patients with advanced heart failure. J Am Coll Cardiol 2017;69:1924–33. - PMC - PubMed
    1. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873–84. - PubMed